Wingate At Silver Lake | |
17 Chipman Way, Kingston, Massachusetts 02364 | |
(781) 585-4100 | |
Name | Wingate At Silver Lake |
---|---|
Location | 17 Chipman Way, Kingston, Massachusetts |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 164 |
Occupancy Rate | 77.38% |
Medicare ID (CCN) | 225544 |
Legal Business Name | Senior Residential Care - Kingston, Inc. |
Ownership Type | For Profit - Corporation |
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Financial pressures kept cancer patients from filling prescription medications and attending their doctors' visits, University of North Carolina Lineberger Comprehensive Cancer Center researchers found in a new study.
By turning down the activity of a specific RNA molecule researchers at Sahlgrenska Academy, Sweden, have cured lung tumors in mice by 40-50 percent.
An experimental Zika vaccine lowered levels of virus in pregnant monkeys and improved fetal outcomes in a rhesus macaque model of congenital Zika virus infection, according to a new study in Science Translational Medicine.
Actavis plc announced today that VIBERZI (eluxadoline) was approved by the Food and Drug Administration as a twice-daily, oral treatment for adults suffering from irritable bowel syndrome with diarrhea (IBS-D). VIBERZI (eluxadoline) has mixed opioid receptor activity, it is a mu receptor agonist, a delta receptor antagonist, and a kappa receptor agonist.
It is estimated that 174,470 new cases of lung cancer will be diagnosed in the United States in 2006. Lung cancer is the major cause of cancer-related mortality in both men and women, with an estimated 162,460 deaths expected to occur in 2006.
› Verified 1 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 4 |
Total Amount of Fines in Dollars | $38031 |
Number of Payment Denials | 0 |
Total Number of Penalties | 4 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 10.05 | 14.46 |
Percentage of long-stay residents who lose too much weight | 6.73 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 49.52 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.5 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 4.46 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0.67 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 2.33 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.73 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 19.48 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 90.34 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 2.07 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 14.29 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 16.2 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 9.06 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.24 | 95.98 |
Percentage of short-stay residents who made improvements in function | 82.67 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 94.36 | 82.93 |
News Archive
Financial pressures kept cancer patients from filling prescription medications and attending their doctors' visits, University of North Carolina Lineberger Comprehensive Cancer Center researchers found in a new study.
By turning down the activity of a specific RNA molecule researchers at Sahlgrenska Academy, Sweden, have cured lung tumors in mice by 40-50 percent.
An experimental Zika vaccine lowered levels of virus in pregnant monkeys and improved fetal outcomes in a rhesus macaque model of congenital Zika virus infection, according to a new study in Science Translational Medicine.
Actavis plc announced today that VIBERZI (eluxadoline) was approved by the Food and Drug Administration as a twice-daily, oral treatment for adults suffering from irritable bowel syndrome with diarrhea (IBS-D). VIBERZI (eluxadoline) has mixed opioid receptor activity, it is a mu receptor agonist, a delta receptor antagonist, and a kappa receptor agonist.
It is estimated that 174,470 new cases of lung cancer will be diagnosed in the United States in 2006. Lung cancer is the major cause of cancer-related mortality in both men and women, with an estimated 162,460 deaths expected to occur in 2006.
› Verified 1 days ago